Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AORT | Common Stock | Options Exercise | $117K | +10.6K | +3.5% | $11.00 | 315K | Feb 7, 2022 | Direct | F1 |
transaction | AORT | Common Stock | Sale | -$184K | -10.6K | -3.38% | $17.30 | 304K | Feb 7, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AORT | StockOption(Right To Buy) | Options Exercise | -$117K | -10.6K | -25% | $11.00 | 31.9K | Feb 7, 2022 | Common Stock | 10.6K | $11.00 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 |
F2 | Reflects weighted average price. Range of prices were between $16.90 to $17.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 |